KIBO-International
ActiveSummary
The computed 12-month bankruptcy probability of KIBO-International is 3.3% (moderate). The 2025 annual accounts show negative equity (-€418,158) and a net result of -€5,501. Equity has been shrinking by about 6.2% per year since 2022. Its solvency ranks better than 5% of 22,773 sector peers (NACE 47, financial year 2025). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Official details
Source: KBO- Status
- Active since 28-05-2021 Normal situation
- Registered office
- 13 active companies are registered at this address 1 started in the 12 months before. Source: KBO register, as of 3 November 2026.
- Activity
- Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses NACE 47741and 1 other
- Establishment unit
- 2.318.972.763 9000 Gent, since 28-05-2021
- Financial year end
- 31 December
- Peppol
- Reachable since 18-03-2025
Board and ownership
- Bossuyt BernardDirector
- Bossuyt PaulineDirector
- De Coninck JohanDirector
- GROEP BOSSUYT50%· score 922025 annual accounts of GROEP BOSSUYT
Financial position
- Bankruptcy probabilitywithin 12 months
- 3.3%
- Gross margin
- €22,332
- ▲ 850%
- Turnover
- ≈ €230,000
- estimated
- Loss
- €5,501
- ▼ 78.3%
- Equity
- -€418,158
- ▼ 1.3%
- Total assets
- €145,237
- ▼ 7.6%
- Negative equity on 31-12-2025
Score breakdownraises risk1 change of registered office in 24 monthsNegative equity -€418,158Founded in 2021lowers riskFigures for financial year 2025 (filed on 08-06-2026)Show the evidence
Checked score
About 3 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 6% of them on solvency, 4% on liquidity, 23% on profitability and 36% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 4 accounts on average 62 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
- Risk: Negative equitydebts exceed assets in financial year 2025 -€418,158 View
- Risk: 4 loss-making years in a rowloss in financial year 2025 -€5,501 View
- Caution: Lower solvency than 95% of companies in retail tradesector median 33.2% · 22,773 companies -287.9% View
- Positive: Always filed on timeaccounts within the deadline every year 4 years View
Recent changes
- · Gazette deed Registered office moved from Gent to Sint-Martens-Latem
- · Gazette deed Resignation: Laura De Coninck (director)
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as KIBO-International: retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses (NACE 47741). They are comparable in size and age: total assets between €82,700 and €325,000, founded between 2018 and 2022.
| Company | Total assets | Gross margin |
|---|---|---|
| KIBO-International Sint-Martens-Latem | €145,237 | €22,332 |
| Trisources Izegem | €176,040 | €27,219 |
| ARO CONCEPTS Hechtel-Eksel | €192,668 | €14,060 |
| CARDON BIO Gent | €324,561 | €25,626 |
| BIONHEUR EN HERBES Koekelberg | €134,564 | €33,301 |
| PRAKTIJK NAENEN Boechout | €82,665 | €32,542 |
| CENTRE AUDITIF CHAIRI Sint-Agatha-Berchem | €103,650 | €25,964 |
Key facts about KIBO-International
- What is the company number of KIBO-International?
- The company number of KIBO-International is 0768.866.738. The VAT number is the same number with BE in front: BE 0768.866.738.
- Where is KIBO-International based?
- The registered office is at Maenhoutstraat 77B, 9830 Sint-Martens-Latem.Company details
- What does KIBO-International do?
- According to the KBO register, the main activity is retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses (NACE 47741).
- What is the legal form of KIBO-International?
- The legal form of KIBO-International is Private limited company (BV).
- When was KIBO-International founded?
- KIBO-International was founded on 28-05-2021.
- Is KIBO-International still active?
- Yes, KIBO-International is an active enterprise in the KBO register.
- What is the turnover of KIBO-International?
- The turnover in financial year 2025 is ≈ €230,000. This figure is estimated from the gross margin of €22,332 and 118 comparable companies (NACE 477). It probably lies between €85,000 and €500,000. It is a rough estimate.Financials
- Is KIBO-International profitable?
- In financial year 2025, KIBO-International made a loss of €5,501.
- Where can I find the annual accounts of KIBO-International?
- KIBO-International filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of KIBO-International due?
- KIBO-International must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.